Answer
Fluenz is indicated for active immunisation to prevent influenza disease in children and adolescents aged 2 years to less than 18 years, in accordance with official recommendations.
Sources for this answer
- Fluenz nasal spray suspension Influenza vaccine (live, nasal)AstraZeneca UK Limited · emc · SmPC §4.1 Therapeutic Indications · Version 4Document updated
Sources checked